JPJaeyu Park

Jaeyu Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaeyu Park has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prenatal Opioid Exposure and Autoimmune‐Related Diseases in Children: A Cohort Study in South Korea and Japan

    by Dongjin Yeo, Hyunjee Kim, Juyeong Kim, Sunyoung Kim, Hyeon Seok Hwang, Jiseung Kang, Jaeyu Park, Hyeon Jin Kim, Dong Keon Yon

    Background: Prenatal opioid exposure has been associated with acute neonatal complications and longer‐term immune‐related outcomes, but its association with autoimmune diseases in children remains unclear. Objectives: To investigate the association between prenatal opioid exposure and the risk of autoimmune diseases in children. Methods: We used the South Korean National Health Insurance Service (NHIS) birth cohort (discovery cohort; 2,930,720 children, 2,188,898 mothers) and the Japan Medical Data Center (JMDC) cohort (replication cohort; 176,528 children, 147,423 mothers). Children born between January 2010 and December 2017 were followed through December 2023. Prenatal opioid exposure was defined as at least two maternal opioid prescriptions during pregnancy. The primary outcome was any autoimmune‐related disease, with 22 prespecified subcategories. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using propensity score overlap‐weighted Cox models. Sibling‐comparison analyses were conducted in both cohorts. Results: In the South Korean cohort, 118,726 children (4.1%) were prenatally exposed to opioids. Exposure was associated with modestly increased risk of autoimmune‐related diseases in overlap‐weighted analyses in both South Korea (HR 1.05, 95% CI 1.02, 1.08) and Japan (HR 1.14, 95% CI 1.09, 1.20), with a pooled HR of 1.10 (95% CI 1.00, 1.20). Risks increased with greater numbers and longer durations of opioid prescriptions. Associations were observed for autoimmune thyroid disease (HR 1.06, 95% CI 1.01, 1.12), autoimmune adrenal and polyglandular diseases (HR 1.07, 95% CI 1.02, 1.12) and reactive arthritis (HR 1.10, 95% CI 1.00, 1.21). However, sibling‐comparison analyses showed no association in South Korea or Japan. Conclusions: The absence of associations in sibling‐comparison analyses suggests that shared familial, genetic or environmental factors may explain the observed population‐level associations rather than a clinically meaningful independent effect of prenatal opioid exposure on autoimmune disease risk in offspring.

  • Age- and sex-specific burden of major depressive disorders and attributable risk factors in high-income regions, 1990-2023

    by Jueun Park, Seohyun Hong, Hyunjee Kim, Dongjin Yeo, Jaehyun Kong, Yoon Lee, Yesol Yim, Juyeong Kim, Jaeyu Park, Sunyoung Kim, et al.

  • Open Access

    Maternal opioid prescriptions and subsequent risk of hospital admission in offspring in South Korea: A nationwide birth cohort study

    by Hyeon Jin Kim, Yesol Yim, Christa J. Nehs, Jaeyu Park, Eun Soo Kim, Sung Joon Cho, Guillaume Fond, Laurent Boyer, Jiseung Kang, Dong Keon Yon

    Background: Prenatal opioid exposure may disrupt infant development and immune system function, potentially increasing long-term susceptibility to hospital admissions. Thus, we aimed to investigate the association between prenatal opioid exposure and the risk of hospital admission in children. Methods and findings: We established a population-based birth cohort in South Korea by linking mothers and children using National Health Insurance Service data and followed from January 1, 2009, to December 31, 2023. We constructed propensity score (PS)-matched and sibling comparison cohorts and performed a multi-pronged approach, including dose-dependent and time-attenuation analyses. All 5,249,429 individuals with eligible children born between January 1, 2010, and December 31, 2017, were included (2,236,167 mothers and 3,013,262 children). Infants were followed up for up to 14 years, depending on birth year. Prenatal exposure to opioids was defined as maternal receipt of two or more prescriptions within any given trimester. Adjusted incidence rate ratio (aIRR) of hospital admission among children with prenatal opioid exposure was estimated for causes including infections, non-infectious respiratory conditions, non-infectious gastrointestinal conditions, oral cavity diseases, injuries/external causes, and non-infectious genitourinary conditions. Analyses were adjusted for maternal age at delivery, infant sex, region of residence, household income level, birth season, parity, severe maternal morbidity score, number of outpatient visits and hospital admissions in the year before pregnancy, preterm birth, low birth weight, delivery type, year of delivery, maternal history of substance use and neuropsychiatric disorders, and plurality. Of the 2,928,186 children, we identified 2,809,515 (51.4% male) and 118,671 (51.3% male) infants without and with prenatal opioid exposure, respectively. The rate of hospital admissions in children with prenatal opioid exposure was 28% higher in the PS-matched cohort (aIRR 1.28 [95% CI 1.28, 1.29]; p < 0.001). The association was attenuated in the sibling comparison cohort, indicating the potential influence of shared familial factors, but remained statistically significant (aIRR 1.08 [95% CI 1.07, 1.10]; p < 0.001). Hospital admission rates in children increased in a dose-dependent manner with maternal opioid dose and duration of opioid prescriptions (low-dose exposure: aIRR 1.19 [95% CI 1.19, 1.20]; p < 0.001; high-dose exposure: aIRR 1.40 [95% CI 1.39, 1.41]; p < 0.001). Prenatal opioid exposure was significantly associated with increased rates of hospital admission across several causes of morbidities, including infections, respiratory non-infections, oral cavity, gastrointestinal non-infections, genitourinary non-infections, and injury/external conditions. These associations between prenatal opioid exposure and hospital admission rates in children diminished with age but remained evident up to five years of age. The main limitations of this study’s methodology include the use of prescription records, which may not fully capture actual medication intake, and residual confounding that cannot be entirely excluded. Conclusions: In this nationwide birth cohort study, maternal opioid prescription during pregnancy was associated with a substantial increase in the risk of hospital admissions in the offspring across various causes of morbidities. Although the attenuated estimates in the sibling comparison analysis suggest that familial factors may partly explain this association, these findings may inform postnatal monitoring and management strategies for children born to mothers who received opioid prescriptions during pregnancy.

  • Open Access

    National trends in chronic kidney disease prevalence by sleep duration in South Korea, 2007 to 2022

    by Jeongseon Oh, Yesol Yim, Hyeon Jin Kim, Sunyoung Kim, Yejun Son, Seoyoung Park, Jaeyu Park, Hyunjee Kim, Lee Smith, Guillermo F. López Sánchez, et al.

    Despite growing evidence linking sleep duration to chronic kidney disease (CKD), long-term trend analyses specific to the Korean population remain limited, and most previous studies have relied on broad intermediate sleep categories. This study analyzed trends in CKD prevalence by self-reported sleep duration among Korean adults. We included 87,246 Korean adults aged ≥19 years from the Korea National Health and Nutrition Examination Survey, 2007 to 2022. CKD was defined as an estimated glomerular filtration rate 2 . Sleep duration was categorized into 5 groups (<6, 6–7, 7–8, 8–9, and ≥9 hours), with 7 to 8 hours as the reference. Weighted linear and logistic regression models provided β-coefficients and weighted odds ratios with 95% confidence intervals, sequentially adjusted for age, sex, body mass index, region, household income, education, smoking status, physician-diagnosed diabetes mellitus, hypertension, and dyslipidemia, and perceived stress. CKD prevalence declined across all 5 categories from 2007 to 2009 to 2020 to 2022 (<6 hours, 5.13% [95% confidence intervals, 4.12–6.13]–3.53% [2.74–4.33]; 7 to 8 hours, 2.37% [1.82–2.93]–1.52% [1.16–1.89]; ≥9 hours, 4.33% [3.17–5.48]–2.95% [2.18–3.72]). A U-shaped association was observed: relative to 7 to 8 hours, the fully adjusted odds of CKD were higher for .05). In conclusion, CKD prevalence showed a U-shaped association with sleep duration that persisted after adjustment for cardiometabolic comorbidity and perceived stress. The absence of a significant change across the pandemic threshold should be interpreted in light of the short observation window relative to the natural history of CKD.

  • Regional and national burden of attention-deficit hyperactivity disorder in Asia, 1990–2023: a Global Burden of Disease Study 2023

    by Yujin Choi, Kyeongeun Kim, Hyunyi Yoo, Dain Y. Kim, Jiseung Kang, Hyunjee Kim, Jeongseon Oh, Ho Geol Woo, José Francisco López-Gil, Christa J. Nehs, et al.

  • Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: A pharmacovigilance study and Global Burden of Disease Study 2023

    by Dain Y. Kim, Hyunjeong Kim, Hyunyi Yoo, Hyoin Shin, Hyunju Yon, Taelim Choi, Junmo Moon, Hyunjee Kim, José Francisco López-Gil, Masoud Rahmati, et al.

  • Open Access

    National trends in the prevalence of depression and suicidal ideation stratified by academic achievement among adolescents, 2006 to 2022 in South Korea

    by Jinyoung Jeong, Jaeyu Park, Jaehyeong Cho, Hyesu Jo, Jeongseon Oh, Hyunjee Kim, Jiyeon Oh, Sooji Lee, Jiseung Kang, Hanseul Cho, et al.

    Although severe depression and suicidal ideation among adolescents could be driven by excessive academic competition, research on this problem is still insufficient. Therefore, this study aims to analyze the relationship between academic achievement, depression, and suicidal ideation based on large-scale data. This study utilized data from the nationwide Korea Youth Risk Behavior Web-based Survey conducted from 2006 to 2022, investigating a total of 1,138,802 adolescents. Weighted proportions with 95% confidence intervals (CIs) and crude numbers and percentages were utilized to analyze and present the results in various formats. To accurately assess the association of academic achievement with depression and suicidal ideation, weighted odds ratios and their 95% CIs were calculated using weighted logistic regression analysis. Compared to students with high academic achievement, those with moderate achievement showed a 1.12 (95% CI = 1.11–1.13) times higher risk of depression, while those with low achievement had a 1.54 (1.52–1.56) times higher risk. Similarly, students with low academic achievement had a 1.49 (95% CI = 1.47–1.51) times higher risk of suicidal ideation. The prevalence of both depression and suicidal ideation decreased before the coronavirus disease 2019 pandemic but steadily increased during the pandemic. Females experienced higher rates of depression in each academic achievement group (high: weighted odds ratio = 1.49 [95% CI = 1.46–1.52]; middle: 1.59 [1.56–1.63]; low: 1.72 [1.69–1.75]) and suicidal ideation (high: 1.60 [1.57–1.64]; middle: 1.63 [1.59–1.68]; low: 1.82 [1.78–1.86]) than males. This study suggests that academic achievement can be associated with depression and suicidal ideation. Therefore, implementing mental health and educational programs targeting students with lower academic achievement may be crucial.

  • Open Access

    Ex vivo Evaluation of Live-MB2 and CX-2 Biotic Strains on Inflammatory and Barrier-Related Biomarkers in a Human Skin Atopic Dermatitis–Like Model

    by Sejin Cheon, Haeun Lee, Da Yeong Nam, Seokjun Kim, Kyeongeun Kim, Jaeyu Park, Dong-Geol Lee, Chun Ho Park, So Min Kang, Young Mok Heo, et al.

    Objective: Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by epidermal barrier disruption and immune dysregulation. Live-MB2 and CX-2 were used in an ex vivo human skin AD-like model, which provides a biologically relevant platform for assessing cosmetic ingredients targeting AD-like features. Methods: An AD-like condition was induced in ex vivo human skin explants by repeated tape stripping followed by 2,4-dinitrochlorobenzene stimulation. Skin tissues were treated with Live-MB2 or CX-2 via topical or dermal exposure. Epidermal thickness, IgE, and filaggrin levels were evaluated using hematoxylin and eosin, immunofluorescence, and Enzyme-Linked Immunosorbent Assay analyses. Results: Topical application of Live-MB2 and CX-2 significantly reduced epidermal thickness compared with AD-induced controls. IgE levels were significantly reduced, while filaggrin expression indicated a marked increase, indicating barrier recovery. No treatment-related tissue damage was observed. Conclusion: Live-MB2 and CX-2 showed favorable effects on inflammatory and barrier-related parameters in an ex vivo human skin AD-like model, supporting their potential application as cosmetic ingredients for sensitive and atopic-prone skin.

  • Open Access

    Comparative burden of HIV and non-HIV sexually transmitted infections in Asia, 1990 to 2023

    by Dain Y. Kim, Jeongseon Oh, Jaeyu Park, Jaehyeong Cho, Jiyeon Oh, Hyeon Jin Kim, Jiseung Kang, Hyesu Jo, Hyunjee Kim, Jee Myung Yang, et al.

    Sexually transmitted infections (STIs) remain an important public health challenge in Asia, yet comparative evidence assessing human immunodeficiency virus (HIV) and non-HIV STIs within a unified regional framework is limited. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2023 estimates, we assessed HIV and non-HIV STIs (including syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes) across 5 Asian subregions (Central, East, South, and Southeast Asia, and high-income Asia Pacific) from 1990 to 2023. We quantified burden using age-standardized disability-adjusted life-year rates and prevalence rates, analyzed temporal trends using estimated annual percentage changes, and examined attributable risk factors including unsafe sex, childhood sexual abuse, drug use, and intimate partner violence. From 1990 to 2023, HIV burden increased across most Asian subregions, while non-HIV STIs generally declined. In 2023, Southeast Asia showed the highest HIV burden and the highest prevalence of non-HIV STIs. HIV exhibited regionally variable age peaks and a predominantly male burden, while non-HIV STIs were concentrated in earlier adulthood and showed discordant sex patterns, with higher prevalence in males but higher disability-adjusted life-year rates in females. Unsafe sex was the leading attributable risk factor across regions, except in Central Asia, where drug use predominated for HIV-attributable burden. These findings underscore the need for differentiated responses across Asia, including sustained HIV-case finding and treatment scale-up, targeted harm reduction, and strengthened STI surveillance and prevention in higher-burden settings.

  • Open Access

    Machine learning for predicting emergency department visits in patients with type 2 diabetes: A real-world, multi-institutional study

    by Sunyoung Kim, Hyunji Sang, Jaeyu Park, Selin Woo, Eun-Hee Cho, Chong Hwa Kim, Dae Jung Kim, Chang-Won Jeong, Tae Sun Park, You-Cheol Hwang, et al.

    Background: Patients with type 2 diabetes mellitus (T2DM) prone to acute diabetic complications are at high risk for emergency department (ED) visits, which often precede hospitalization and mortality. Identifying these high-risk phenotypes before deterioration is critical for preventative care. We developed machine learning (ML) models using large-scale, real-world electronic medical records, including prescription data, to predict the possibility of ED visits in patients with T2DM and support proactive interventions in primary care settings. Methods: We analyzed the electronic health record data of five independent institutions, creating a comprehensive dataset of 220,720 patients. The data included dynamic clinical parameters such as vital signs, laboratory results, and prescription histories. The cohort was randomly split into a training set ( n = 176,576) and a test set ( n = 44,144). The primary outcome was the first ED visit. We developed multiple ML models using an automated ML framework and optimized them using hyperparameter tuning of the training set. Model performances were evaluated using the area under the receiver operating characteristic (AUROC) curve, and feature importance was analyzed using SHAP values to ensure interpretability. Results: Among the screened population, 49,770 (22.6%) experienced at least one ED visit, distributed proportionally across the training and test datasets. The CatBoost model demonstrated superior predictive performance, achieving an AUROC of 0.87 (95% CI, 0.862–0.871) on the test dataset. The model identified modifiable risk factors as key predictors; Diastolic blood pressure was the most significant variable, followed by serum creatinine and systolic blood pressure. Conclusions: This ML-based predictive model can accurately identify high-risk patients with T2DM who are likely to visit the ED based on readily available clinical variables. By enabling healthcare providers to shift from reactive treatment to proactive risk management, it has the potential to reduce the burden of ED visits due to acute complications in T2DM.